[1] WOOD L D, CANTO M I, JAFFEE E M, et al. Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment[J]. Gastroenterology, 2022, 163(2): 386-402. DOI: 10.1053/j.gastro.2022.03.056. [2] YAN H J, LI Q, WU J, et al. MiR-629 promotes human pancreatic cancer progression by targeting FOXO3[J]. Cell Death Dis, 2017, 8(10): e3154. DOI: 10.1038/cddis.2017.525. [3] WANG Y, XU Y M, ZOU Y Q, et al. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions[J]. Medicine, 2017, 96(44): e8361. DOI: 10.1097/MD.0000000000008361. [4] GE Q W, SHI Z Y, ZOU K A, et al. Protein phosphatase PPM1A inhibition attenuates osteoarthritis via regulating TGF-β/Smad2 signaling in chondrocytes[J]. JCI Insight, 2023, 8(3):e166688. DOI: 10.1172/jci.insight.166688. [5] 周亚莉,胡文君,高尧颖,等.蛋白磷酸酶PPM1A的研究进展[J].生理科学进展, 2018, 49(5): 363-366. DOI: 10.3969/j.issn.0559-7765.2018.05.010. [6] BRABLETZ S, SCHUHWERK H, BRABLETZ T, et al. Dynamic EMT: a multi-tool for tumor progression[J]. EMBO J, 2021, 40(18): e108647. DOI: 10.15252/embj.2021108647. [7] PAN G T, LIU Y H, SHANG L R, et al. EMT-associated microRNAs and their roles in cancer stemness and drug resistance[J]. Cancer Commun, 2021, 41(3): 199-217. DOI: 10.1002/cac2.12138. [8] YANG J, ANTIN P, BERX G, et al. Guidelines and definitions for research on epithelial-mesenchymal transition[J]. Nat Rev Mol Cell Biol, 2020, 21(6): 341-352. DOI: 10.1038/s41580-020-0237-9. [9] 王旭, 程合, 刘辰, 等.2022年度胰腺癌研究及诊疗新进展[J].中国癌症杂志, 2023, 33(1): 1-13. DOI: 10.19401/j.cnki.1007-3639.2023.01.001. [10] HUANG Y H, HONG W Q, WEI X W. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis[J]. J Hematol Oncol, 2022, 15(1): 129. DOI: 10.1186/s13045-022-01347-8. [11] LUO Z H, CHEN S J, CHEN X G. CircMAPK9 promotes the progression of fibroblast-like synoviocytes in rheumatoid arthritis via the miR-140-3p/PPM1A axis[J]. J Orthop Surg Res, 2021, 16(1):395. DOI: 10.1186/s13018-021-02550-y. [12] ZHANG Y, TAO R, WU S S, et al. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A[J]. J Exp Clin Cancer Res, 2018, 37(1): 1-13. DOI: 10.1186/s13046-018-0780-9. [13] MAZUMDAR A, TAHANEY W M, REDDY BOLLU L, et al. The phosphatase PPM1A inhibits triple negative breast cancer growth by blocking cell cycle progression[J]. NPJ Breast Cancer, 2019, 5: 22. DOI: 10.1038/s41523-019-0118-6. [14] HO P T B, CLARK I M, LE L T T. MicroRNA-based diagnosis and therapy[J]. Int J Mol Sci, 2022, 23(13): 7167. DOI: 10.3390/ijms23137167. [15] HUSSEN B M, RASUL M F, ABDULLAH S R, et al. Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges[J]. Mil Med Res, 2023, 10(1): 32. DOI: 10.1186/s40779-023-00468-6. ( |